Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Vitro Diagnostics (VODG) had Revenue of $0.45M for the most recently reported fiscal quarter, ending 2026-04-30.

Quarterly Annual

Figures for fiscal quarter ending 2026-04-30

Income Statement Financials
Revenue	$0.45M
Net Income	$-1.59M
Cost of Goods Sold	$0.10M
Gross Profit	$0.34M
Operating Expenses	$1.62M
Operating Income	$-1.17M
Non-Operating Income/Expense	$-0.38M
Pre-Tax Income	$-1.55M
Normalized Pre-Tax Income	$-1.55M
Income after Taxes	$-1.55M
Income from Continuous Operations	$-1.55M
Consolidated Net Income/Loss	$-1.55M
Normalized Income after Taxes	$-1.55M
EBIT	$-1.17M
EBITDA	$-0.67M
Weighted-Average Shares Outstanding (Basic)	4.52M
Weighted-Average Shares Outstanding (Diluted)	4.52M
Earnings per Share (EPS) (Basic)	$-0.35
Earnings per Share (EPS) (Diluted)	$-0.35
Balance Sheet Financials
Current Assets	$0.36M
Property, Plant, and Equipment	$0.06M
Long-Term Assets	$4.01M
Total Assets	$4.37M
Current Liabilities	$16.63M
Long-Term Debt	$3.29M
Long-Term Liabilities	$4.28M
Total Liabilities	$20.91M
Common Equity	$-16.53M
Tangible Shareholders Equity	$-20.18M
Shareholders Equity	$-16.53M
Common Shares Outstanding	4.52M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-1.54M
Cash Flow from Investing Activities	$-0.04M
Cash Flow from Financial Activities	$1.10M
Beginning Cash	$0.60M
End Cash	$0.12M
Increase/Decrease in Cash	$-0.48M
Stock-Based Compensation	$0.53M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	0.02
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	-0.25
Debt to Equity Ratio	-0.61
Gross Margin	76.74%
Operating Margin	-262.62%
EBIT Margin	-262.62%
EBITDA Margin	--
Pre-Tax Profit Margin	-348.03%
Profit Margin	-356.97%
Free Cash Flow	$-1.57M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.10
Inventory Turnover	0.75
Receiveable Turnover	7.17
Days Sales in Receivables	12.55
Return on Equity	9.39%
Return on Tangible Equity	7.70%
Return on Assets	-35.50%
Return on Investments	11.73%
Book Value Per Share	$-3.66
Free Cash Flow per Share	$-0.35
Operating Cash Flow per Share	$-0.34

Data from Zacks Investment Research, Inc.